胃肠道癌

  • 网络gastrointestinal cancer;gastrointestinal carcinoma
胃肠道癌胃肠道癌
  1. LFO方案治疗晚期胃肠道癌近期疗效观察

    The observation of LFO therapy effect in advanced gastrointestinal cancer

  2. 目的:探讨小剂量醛氢叶酸(LDCF)、氟尿嘧啶(5Fu)与顺铂(PDD)三药联用治疗晚期胃肠道癌的临床疗效。

    Objective : To study the immediate response of advanced gastrointestinal cancer treated with low dose of leucovorin ( LDCF )、 5 Fu and PDD .

  3. 目的:探讨循环中抗癌胚抗原(CEA)特异性抗体的情况,评价CEA及抗体的联合检测在胃肠道癌诊断中的作用。

    Objective : To evaluate the diagnostic significance of CEA specific antibodies in the serum of patients with gastrointestinal malignancies .

  4. 结论:HCPT方案联合化疗治疗晚期胃肠道癌,有效率高,毒副反应无明显增加,值得在临床中推广使用。

    Conclusion : The combination chemotherapy with HCPT is effective and safe for gastroenteric carcinoma .

  5. 胃肠道癌术后化疗T细胞亚群和sIL-2R的比较研究

    Comparative Research of the Serum T-lymphocyte Subsets ( T-LS ) and sIL-2R of Postoperative Chemotherapy of Patients with Gastrointestinal Carcinoma

  6. 结论:HCPT联合化疗方案治疗晚期胃肠道癌安全有效,是一种可行的方案。

    Conclusion : HCPT based combination chemotherapy is effective and safe for advanced gastrointestinal tract cancer .

  7. 乳腺癌、胃肠道癌皮肤转移CK18和CK20及CEA的表达

    Expression of CK18 , CK20 and CEA in cutaneous metastases from breast and gastrointestinal carcinoma

  8. 目的探讨胃肠道癌患者外周血T细胞亚群和CD8+T细胞CD28共刺激分子等功能相关性标志物的表达及意义。

    Objective To investigate the significance of CD8 + T lymphocyte function-related makers and changes of T lymphocyte subsets in patients with gastrointestinal carcinoma .

  9. 结论:胃肠道癌患者血清中抗癌胚抗原(CEA)抗体的检出率较高,这些抗体可作为胃肠道癌的一种肿瘤标志物。

    Conduskm : In this study , a high number of gastrointestinal malignancies patients have circulating CEA specific antibodies in their sera and these antibodies may be used as diagnostic markers .

  10. 目的:探讨胃肠道癌术中腹腔内温热化疗(IPHC)防治腹膜转移的临床适应证。

    To establish the clinical indications of intraoperative peritoneal hyperthermic chemotherapy ( IPHC ) for gastrointestinal malignancy .

  11. 晚期胃肠道癌应用Melodie泵时辰化疗的临床研究

    Clinical study of chrono-chemotherapy for advanced gastrointestinal cancers by melodie infusion pump

  12. 目的探索不同剂量方克(替加氟)联合草酸铂治疗胃肠道癌的最大耐受剂量(MTD)和剂量限制性毒性(DLT)。

    Objective To determine the maximum-tolerated dose ( MTD ) and dose-limiting toxicity ( DLT ) of tegafur and oxaliplatin in patients with gastrointestinal cancers .

  13. 目的:研究晚期胃肠道癌应用Melodie泵时辰化疗的近期疗效和耐受性。

    OBJECTIVE : To evaluate the efficacy and toxicity of chrono-chemotherapy for advanced gastrointestinal cancers by melodie infusion pump .

  14. 5-ALA在皮肤癌、食道癌、胃肠道癌及肺癌等领域已经研究相当广泛,并且已经有相当程度的临床应用。

    5-ALA has been widely studied and clinically applied in the skin cancer , esophagus , gastrointestinal tract cancer and lung cancer .

  15. 出血量<6ml,血肿范围<2cm,预后好;这些结果提示AAT和AACT阳性胃肠道癌预后较好,AAT和AACT可能是反映胃肠道癌预后的重要生物学标记物。

    The results suggested that the positive gastrointestinal cancer of AAT and / or AACT might have a good prognosis , AAT and AACT might be important biological markers in reflecting the prognosis of gastrointestinal cancer .

  16. 方法将36例胃肠道癌患者分两组,每组18例,一组接受腹腔化疗,另一组接受静脉化疗,检测血清中T细胞亚群和sIL2R水平。

    Methods 36 patients were divided into two groups each with 18 cases , one group received EPIC and the other IVC , then determined the serum T-lymphocyte subsets ( T LS ) and sIL-2R before and after the chemotherapy .

  17. 胃癌根治术中腹腔温热化疗结合MMC-CH疗效评价方法对53例进展期胃肠道癌病人分组行围手术期持续腹腔温热化疗,并对其化疗术后1、2、3年生存率对照研究。

    The Evaluation of the Curative Effect on Intraperitoneal Chemo-hyperthermia in Combination with MMC-CH in Radical Surgery of Gastric Cancer Methods 53 patients were divided into treated and control group . The 1,2 and 3 year survival rates of each group were analyzed .

  18. 胃肠道癌术中腹腔内温热化疗临床适应证的探讨

    Establishing Clinical Indications of Intraoperative Peritoneal Hyperthermic Chemotherapy for Gastrointestinal Malignancy

  19. 胃肠道癌患者围手术期输血与术后感染

    Perioperative transfusion and postoperative infection in the patients with gastrointestinal carcinoma

  20. 胃肠道癌根治手术与辅助性化疗的临床应用

    Clinical application of radical operation on gastrointestinal cancer and assistant chemotherapy

  21. 抗肿瘤免疫核糖核酸对胃肠道癌术后病人细胞免疫皮内试验的影响

    Effect of antineoplasmic iRNA on cellular immune intradermal test of postoperative patients

  22. 胃肠道癌术后早期腹腔化疗的临床分析

    Clinical analysis of early postoperative intraperitoneal chemotherapy for gastrointestinal cancer

  23. 脂类及脂蛋白在胃肠道癌患者中的作用

    Role of lipid and lipoprotein in gastrointestinal tract cancer patients

  24. 全身化疗并大剂量654-2治疗胃肠道癌性疼痛的疗效观察

    Clinical Observation of Chemotherapy and Anisodamine Hydrobromide for Digestive System Tumor Pain

  25. 胃肠道癌经动脉导管化疗的临床应用

    Clinical Application of Chemotherapy by Artery Catheter in Gastroenteric Cancer

  26. 胃肠道癌患者腹腔灌注化疗的操作与护理体会

    Intraperitoneal Chemotherapy and Nursing of Carcinoma of Large Intestine

  27. 胃肠道癌胃大部切除术后残胃功能障碍的诊断与治疗

    Treatment and Diagnosis of Functional Gastric Atony After Subtotal Gastrectomy of Gastroenteric Cancer

  28. 胃肠道癌术后腹腔持续热灌注化疗持续热灌注腹腔化疗在胃肠肿瘤治疗中作用的研究

    Continuous Hyperthermia Peritoneal Perfusion for the Treatment of Advanced Gastrointestinal Carcinoma after Operation

  29. 胃肠道癌复合治疗仪测控系统的设计

    The Design of Measure and Control System for Composite Treating Instrument of Gastrointestinal Cancer

  30. 肝切除治疗胃肠道癌肝转移14例报告

    Treatment of gastrointestinal carcinoma with hepatic metastasis by hepatectomy : report of 14 cases